Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

236
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
236
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
80
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

127
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
127
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

94
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
94
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

59
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Resolution Colony Images of Clinically Isolated Bacteria for Automated Detection and Deep Learning.

Scientific data·2026
Same author

Chiral Plasmonic Nanostructures: Advances in Synthesis and Bio-Detection Applications.

Nano letters·2026
Same author

Machine Learning-Based Prediction of In-Hospital Mortality in Severe COVID-19 Patients Using Hematological Markers.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale·2025
Same author

Development of machine learning-based differential diagnosis model and risk prediction model of organ damage for severe Mycoplasma pneumoniae pneumonia in children.

Scientific reports·2025
Same author

The effect and application of adiponectin in hepatic fibrosis.

Gastroenterology report·2024
Same author

Preparation and Characterization of C-Reactive Protein Dual-Particle Latex-Enhanced Immunoturbidimetric Reagents.

BME frontiers·2024

Related Experiment Video

Updated: May 10, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

47.1K

Development and Validation of Predictive Models for Inflammatory Bowel Disease Diagnosis: A Machine Learning and

Rongrong Dong1, Yiting Wang2, Han Yao1

  • 1Department of Laboratory Medicine, First Hospital of Jilin University, Changchun, 130021, People's Republic of China.

Journal of Inflammation Research
|April 21, 2025
PubMed
Summary

This study developed machine learning and nomogram models using laboratory data to predict inflammatory bowel disease (IBD), Crohn's disease (CD), and Ulcerative colitis (UC). These models show good diagnostic capability, offering a new approach for IBD diagnosis.

Keywords:
Crohn’s diseaseinflammatory bowel diseasemachine learningnomogramulcerative colitis

More Related Videos

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

8.9K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

66.9K

Related Experiment Videos

Last Updated: May 10, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

47.1K
Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

8.9K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

66.9K

Area of Science:

  • Gastroenterology and Hepatology
  • Medical Informatics
  • Biostatistics

Background:

  • Inflammatory bowel disease (IBD) encompasses chronic, incurable gastrointestinal conditions like Crohn's disease (CD) and Ulcerative colitis (UC).
  • Current diagnostic methods for IBD lack a definitive gold standard, necessitating improved predictive tools.

Purpose of the Study:

  • To develop and validate predictive models for diagnosing IBD, CD, and UC.
  • To compare the efficacy of machine learning (ML) and traditional nomogram models in IBD diagnosis.

Main Methods:

  • Utilized three cohorts with initial laboratory test data from UK Biobank, the First Hospital of Jilin University, and a Chinese tertiary hospital.
  • Developed ML models using LightGBM and XGBoost algorithms, and nomogram models via Logistic regression.
  • Validated model performance using Area Under the Curve (AUC) metrics in independent cohorts.

Main Results:

  • Machine learning models demonstrated exceptional discrimination across cohorts, with AUCs ranging from 0.772 to 0.932 for CD and UC predictions.
  • Nomogram models exhibited good diagnostic capability, with validated AUCs for IBD, CD, and UC ranging from 0.758 to 0.817 in the external testing cohort.
  • Both ML and nomogram approaches showed promising predictive performance for IBD subtypes.

Conclusions:

  • Developed risk prediction models for IBD, CD, and UC using conventional laboratory data and integrated ML and nomogram techniques.
  • The models demonstrated good diagnostic capability and were successfully validated in an independent cohort, suggesting clinical utility.
  • This study offers a novel, data-driven approach to enhance the diagnostic accuracy of inflammatory bowel diseases.